Method for establishing the sensitivity of tumours to capecitabin and test kit
US9316644B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2007 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Mar 17, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91142
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to a method for establishing the sensitivity of tumors towards capecitabine, if applicable in combination with Docetaxel or Paclitaxel or the humanized antibody Herceptin, or COX-2 inhibitors or angiogenesis inhibitors and test kit.Fields of application of the invention are the pharmaceutical industry and bio-sciences: biology, biochemistry, biotechnology, medicine and medicinal technology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.